CPEX Pharmaceuticals Report issue

For profit Phase 2
Founded: Exeter NH United States (2007)
Status: Defunct (2011)

Organization Overview

First Clinical Trial
2009
NCT00850096
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now

Alternative names

CPEX Pharmaceuticals Inc.

Active Ingredients

Drugs in Phase 2 Trials (2)

insulin human (humulin) (2 trials)

insulin lispro (humalog) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetes Mellitus, Type 1 (Phase 2)

Diabetes Mellitus, Type 2 (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 2